Aarhus-biotek tager kampen op mod neuromuskulære sygdomme | Indblik+
NMD Pharma to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
News — NMD Pharma
Biopeople Newsletter January 2020 - Biopeople
.jpg "NMD Pharma treats first patient with the firm's most promising drug candidate")
NMD Pharma treats first patient with the firm's most promising drug candidate
NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth
NMD Pharma Information | NMD Pharma Profile
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma Receives Grant from The Innovation Fund Denmark
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Biotech completes financing round to advance neuromuscular treatments - EPM Magazine
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Management — NMD Pharma
Management — NMD Pharma
NMD Pharma treats first patient with the firm's most promising drug candidate
NMD Pharma treats first patient with the firm's most promising drug candidate
NMD Pharma
Management — NMD Pharma
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
Katja Krustrup Pedersen - Research Scientist and Project Manager - NMD Pharma | LinkedIn
NMD Pharma - Inkef capital
NMD Pharma A/S | LinkedIn
